Data Bridge Market Research analyses a growth rate in the global antidotes market in the forecast period 2022-2029. The expected CAGR of global antidotes market is tend to be around 9.0% in the mentioned forecast period. The market was valued at USD 1.74 billion in 2021, and it would grow upto USD 3.47 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

The global antidotes market is expected to witness significant growth during the forecast period. Rising markets and major investment in R&D are the drivers responsible for the growth of this market. The growth of the antidotes market boosted by the rising cases of snake bites and drug overdose and increase R&D activities. In addition to this, major advances in the treatment options and the emergence of well-established healthcare facilities are some of the impacting factors for the demand of antidotes drugs. COVID-19 also had a major impact on the market growth.

Read More : https://www.databridgemarketresearch.com/reports/global-antidotes-m...

Drivers

Increase in Snake bites
According to the WHO, more than 5 million people globally are bitten by snakes, out of which approximately 100,000 develop severe sequelae. In India, mortality is around 30,000; in the U.S., it was around 50,000 cases of bites. This boost the market growth.

Rising Demand for Oral Drugs
Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.

Antidotes Market Scope

The global antidotes treatment market is segmented on the basis of type, end-user, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

Chemical Antidotes
Pharmacological Antidotes
Others
End User

Hospitals
Homecare
Specialty Clinics
Others
Distribution Channel

Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Antidotes Market Regional Analysis/Insights
The global antidotes market is analysed and market size insights and trends are provided by type, end-user, distribution channel as referenced above.

The major countries covered in the global antidotes market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing a positive growth for antidotes market throughout the forecasted period due to rising prevalence of poison cases and rise in R&D activities for antidotes.

Asia-Pacific dominates the market due to the large number of generic manufacturer, developing healthcare facilities, and rise in initiatives from the government and specialist communities.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Global Antidotes Market Share Analysis
The global antidotes market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global antidotes market

Key players operating in the global antidotes market include:

Pfizer Inc (U.S.)
Hikma Pharmaceuticals PLC (U.K.)
Dr. Reddy’s Laboratories Ltd (India)
Aurobindo Pharma (India)
Mylan N.V. (U.S.)
Akorn Operating Company LLC (U.S.)
Alvogen (U.S.)
Fresenius Kabi AG (Germany)
Zydus Cadila (India)
Daiichi Sanko Inc (Japan)
Nichi-Iko Pharmaceutical Co., Ltd (Japan)